Skip to main content

Displaying results 1 - 2 of 2
  • Content Type: Abstract

    Adverse drug events (ADEs) are a major cause of morbidity and mortality. However, post-marketing surveillance systems are passive and reporting is generally not mandated. Thus, many ADEs go unreported, and it is difficult to estimate and/or… read more
    … 3. Psaty BM, Korn D. Congress responds to the IOM drug safety report-in full. JAMA. 2007;298:2185�7. …
  • Content Type: Abstract

    Adverse drug events (ADEs) are a significant source of morbidity and mortality. The majority of post-marketing surveillance for ADEs is passive. Information regarding ADEs is reported to the medical community in peer-reviewed journals. However, in… read more
    … to the editor; signal detection References 1. Chapman WW, Chu D, Dowling JN. ConText: an algorithm for identifying …